Skip to main navigation Skip to search Skip to main content

A phase II study of bortezomib in the treatment of metastatic malignant melanoma

  • Svetomir N. Markovic
  • , Susan M. Geyer
  • , Fitzroy Dawkins
  • , William Sharfman
  • , Mark Albertini
  • , William Maples
  • , Paula M. Fracasso
  • , Tom Fitch
  • , Patricia LoRusso
  • , Alex A. Adjei
  • , Charles Erlichman

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase II study of bortezomib in the treatment of metastatic malignant melanoma'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases